AU4155389A - LO/CO inhibiting benzoxazolones - Google Patents

LO/CO inhibiting benzoxazolones

Info

Publication number
AU4155389A
AU4155389A AU41553/89A AU4155389A AU4155389A AU 4155389 A AU4155389 A AU 4155389A AU 41553/89 A AU41553/89 A AU 41553/89A AU 4155389 A AU4155389 A AU 4155389A AU 4155389 A AU4155389 A AU 4155389A
Authority
AU
Australia
Prior art keywords
benzoxazolones
inhibiting
inhibiting benzoxazolones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU41553/89A
Other versions
AU607866C (en
AU607866B2 (en
Inventor
Fumitaka Ito
Toshihide Kokura
Masami Nakane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU4155389A publication Critical patent/AU4155389A/en
Application granted granted Critical
Publication of AU607866B2 publication Critical patent/AU607866B2/en
Publication of AU607866C publication Critical patent/AU607866C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU41553/89A 1988-09-19 1989-09-19 LO/CO inhibiting benzoxazolones Ceased AU607866C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63-234539 1988-09-19
JP63234539A JPH0283376A (en) 1988-09-19 1988-09-19 Benzoxazolone derivative and antiallergic or anti-inflammatory composition

Publications (3)

Publication Number Publication Date
AU4155389A true AU4155389A (en) 1990-03-22
AU607866B2 AU607866B2 (en) 1991-03-14
AU607866C AU607866C (en) 1992-06-25

Family

ID=

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU616608B2 (en) * 1989-07-20 1991-10-31 Pfizer Inc. 4,5,6,7-tetrasubstituted benzoxazolones
AU617041B2 (en) * 1989-02-28 1991-11-14 Pfizer Inc. Anti-inflammatory 6-substituted amino benzoxazolin-2-one derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617041B2 (en) * 1989-02-28 1991-11-14 Pfizer Inc. Anti-inflammatory 6-substituted amino benzoxazolin-2-one derivatives
AU616608B2 (en) * 1989-07-20 1991-10-31 Pfizer Inc. 4,5,6,7-tetrasubstituted benzoxazolones

Also Published As

Publication number Publication date
ZA897096B (en) 1991-04-24
IL91677A0 (en) 1990-04-29
KR900004706A (en) 1990-04-12
HU202506B (en) 1991-03-28
EP0360566A2 (en) 1990-03-28
AU607866B2 (en) 1991-03-14
KR920007497B1 (en) 1992-09-04
IE892982L (en) 1990-03-19
FI894403A0 (en) 1989-09-18
DK458789A (en) 1990-03-20
NO893713L (en) 1990-03-20
DK458789D0 (en) 1989-09-18
EP0360566A3 (en) 1990-08-22
JPH0283376A (en) 1990-03-23
HUT53360A (en) 1990-10-28
NO893713D0 (en) 1989-09-18
PT91742A (en) 1990-03-30
FI894403A (en) 1990-03-20

Similar Documents

Publication Publication Date Title
AU3151689A (en) Improved cryo-slammer
AU3715993A (en) N-isopropylheteroaryloxyacetanilides
AU3810989A (en) Compounds
AU4261289A (en) Substituted 9h-purines
AU2864489A (en) 16-dehydro-vitamin d3-derivatives
AU7947991A (en) Compounds
AU3642589A (en) 1-aryl-2-naphthoylamines
AU3091089A (en) Substituted sulphonylaminoazoles
AU3163389A (en) 5-amino-1-phenylpyrazoles
AU4169089A (en) (Diarylmethoxy)-1-pyrrolidines and-piperidines
AU3234289A (en) Co-dispenser
AU3334389A (en) Rutheniumcomplex-compounds
AU618619B2 (en) Novel combination
AU4628489A (en) Assayomate
AU4471189A (en) Substituted oxadiaminobutanes
AU3300089A (en) Triazoloazines
AU3315089A (en) 2-substituted-2-cyclopentenones
AU3869789A (en) Pyrazolo-pyrrolo-pyrimidine-diones
AU3491189A (en) Substituted dibenzothiaphenes
ZA897096B (en) Lo/co inhibiting benzoxazolones
AU3508989A (en) Des-17-histidine-calcitonin
AU4679689A (en) Polyhydroxybenzylpxypropanolamines
AU2508688A (en) Yacht-hull
AU3851189A (en) Recombinomas
AU3526789A (en) Sulphonylaminoguanidinoazine compounds